Wei Ding
12Patents
4h-index
54Co-inventors
63Inventor score
Filing activity: Mar 4, 1999 → Feb 4, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6225451A | Chromosome 11-linked coronary heart disease susceptibility gene CHD1 | Physics | 18 | Expired |
| US8409205B2 | Fixation device for intramedullary nail | Human Necessities | 10 | Active |
| US7807644B2 | Chimeric proteins with phosphatidylserine binding domains | Chemistry; Metallurgy | 4 | Active |
| US7727924B2 | Method to raise the solid content of catalytic cracking catalyst slurry | Performing Operations; Transporting | 4 | Active |
| US7393833B2 | Chimeric proteins with phosphatidylserine binding domains | Chemistry; Metallurgy | 1 | Expired |
| US11493685B2 | Polarization-maintaining hollow-core antiresonant fiber | Physics | 1 | Active |
| US11111152B2 | Preparation method for modified molecular sieve and modified molecular sieve-containing catalytic cracking catalyst | Chemistry; Metallurgy | 0 | Active |
| US11633427B2 | Vaccine and uses thereof in cell therapy | Chemistry; Metallurgy | 0 | Active |
| US11944645B2 | Modified cell and use thereof in gene and cell therapy | Chemistry; Metallurgy | 0 | Active |
| US11643439B2 | Multi-target compound with anticoagulation and antiplatelet activity, preparation method therefor, and use thereof | Chemistry; Metallurgy | 0 | Active |
| US11028111B2 | Compound for treating metabolic diseases and preparation method and use thereof | Chemistry; Metallurgy | 0 | Active |
| US11833174B2 | Modified cell with enhanced functionality and cellular therapy thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.